France Neurology Monitoring Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Neurology Monitoring is growing as a result of rising incidences of neurological disorders, brain injuries, and growing geriatric population. This demand is fueling the advancements in technology for development of better neurology monitoring tools and methods for the early detection and accurate diagnosis of neurological disorders. Some of the key players in the global Neurology Monitoring Market include Natus Medical Inc., Nihon Kohden Corporation, Compumedics Limited, Medtronic Plc, Dragerwerk Ag & co. Kgaa, Masimo Corporation, GE Healthcare, Siemens Healthineers, Philips Healthcare, and Advanced Brain Monitoring Inc.
France Neurology Monitoring Market is valued at around $117.7 Bn in 2022 and is projected to reach $187.6 Bn by 2030, exhibiting a CAGR of 6% during the forecast period 2023-2030.
Due to the rising incidence of neurological disorders, especially in the geriatric population, and the rising need for neurology patient monitoring equipment, the global market for neurology monitoring is expanding rapidly. According to the American Medical Association (AMA), by 2030, at least 60% of people aged 65 and older will be living with more than one chronic condition.
Monitoring brain and neurological processes is crucial because of the increase in neurological disorders. In addition, various diseases and problems that are becoming more common, like sickle-cell anemia and heart issues are other important factors influencing the demand for brain monitoring devices as there is the possibility that cardiac procedures can interfere with the brain's regular function.
Pharmaceutical and biotechnology firms like Natus Medical Inc., Nihon Kohden Corporation, Compumedics Limited, Medtronic Plc, Dragerwerk Ag & Co. Kgaa, Masimo Corporation, GE Healthcare, Siemens Healthineers, Philips Healthcare, Advanced Brain Monitoring Inc., are some of the major players in the Neurology Monitoring Market.
The Neurology Monitoring market is expected to offer significant growth opportunities due to the rise in the global elderly population. Progressive neurological diseases and illnesses are more common as people age as older brains are more vulnerable to neurodegenerative disorders like Alzheimer's and Parkinson's.
The market for neurology services is expected to increase favorably as a result of the rising number of patient care campaigns. These activities frequently aid in increasing public awareness of the condition, how it may be identified or recognized early, and how to recognize the signs.
Drivers of France Neurology Monitoring Market:
Growing Incidence of Neurological Disorders: The increasing burden of neurological disorders and the growing burden of traumatic brain injuries is expected to grow the market for Neurology Monitoring.
Advancement in Technology: With advancements in technology, noninvasive evaluation of MEG and EEG data produced by electrically active brain tissue is possible. As a result, the market for Neurology Monitoring is expected to grow with the introduction of new technology.
Growing Geriatric Population: Older people are more prone to neurological disorders which could be a driving factor for the growth of the Neurological Monitoring market.
In 2022, Royal Philips received the U.S. Food and Drug Administration approval for its SmartSpeed artificial intelligence (AI) powered MR acceleration software. This software increases resolution by up to 65% and achieves up to 3 times faster scanning times compared to conventional MR scans.
In 2022, Cerebriu and Siemens Healthineers entered a partnership to integrate Cerebriu's patented Smart Protocol for Brain MRI workflow automation software with the MRI machines of Siemens Healthineers.
In 2022, Compumedics Ltd. reached a significant milestone in the ongoing development of its global MEG business with the confirmation of its first MEG contract in Asia to the Tianjin Normal University (TJNU) in Tianjin, China.
In 2022, Masimo's brain-monitoring headset received FDA approval for use in kids. The SedLine sensors and monitoring system have now been adapted to fit children between the ages of 1 and 17. The system helps physicians monitor brain activity while patients are sedated, detecting signs of potential reactions to the anesthesia.
Key players
Natus Medical France SARL Cadwell France SAS Medtronic France Nihon Kohden France SAS Compumedics France SAS Philips Healthcare France Inomed Medizintechnik GmbH (French branch) Masimo France SAS Moberg Research, Inc. (French distributor) Delsys Inc. (French distributor)1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product Type:
By Disease Type:
By Application:
By Procedure:
By End-user:
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.